Controversies in ammonia metabolism: Implications for hepatic encephalopathy

Metabolic Brain Disease

Volumn 22, Issue 3-4, 2007, Pages 285-289

  Lockwood, Alan H ^a,b  

^a UNIVERSITY AT BUFFALO   (United States)

^b VA WESTERN NEW YORK HEALTHCARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMMONIA; GLUTAMINE; NITROGEN 13; OXYGEN 15;

ALKALINIZATION; BLOOD SAMPLING; BRAIN BLOOD FLOW; CHEMICAL ANALYSIS; CONFERENCE PAPER; HEPATIC ENCEPHALOPATHY; HUMAN; POSITRON EMISSION TOMOGRAPHY;

AMMONIA; ANIMALS; BRAIN; CEREBROVASCULAR CIRCULATION; HEPATIC ENCEPHALOPATHY; HUMANS;

EID: 35449001050     PISSN: 08857490     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11011-007-9059-0     Document Type: Conference Paper

References (21)

1. Ahl B, Weissenborn K, van den Hoff J, Fischer-Wasels D, Kostler H, Hecker H, Burchert W (2004). Regional differences in cerebral blood flow and cerebral ammonia metabolism in patients with cirrhosis. Hepatology 40:73-79
2. Cerra FB, Cheung NK, Fischer JE, Kaplowitz N, Schiff ER, Dienstag JL, Bower RH, Mabry CD, Leevy CM, Kiernan T (1985) Disease-specific amino acid infusion (F080) in hepatic encephalopathy: a prospective, randomized, double-blind, controlled trial. JPEN J Parenter Enteral Nutr 9:288-295
3. Cooper AJ, McDonald JM, Gelbard AS, Gledhill RF, Duffy TE (1979) The metabolic fate of 13N-labeled ammonia in rat brain. J Biol Chem 254:4982-4992
4. Eriksson LS, Conn HO (1989) Branched-chain amino acids in the management of hepatic encephalopathy: an analysis of variants. Hepatology 10:228-246
5. Fischer JE, Yoshimura N, Aguirre A, James JH, Cummings MG, Abel RM, Deindoerfer F (1974) Plasma amino acids in patients with hepatic encephalopathy. Effects of amino acid infusions. Am J Surg 127:40-47
6. Fischer JE, Rosen HM, Ebeid AM, James JH, Keane JM, Soeters PB (1976) The effect of normalization of plasma amino acids on hepatic encephalopathy in man. Surgery 80:77-91
7. Gjedde A, Lockwood AH, Duffy TE, Plum F (1978) Cerebral blood flow and metabolism in chronically hyperammonemic rats: effect of an acute ammonia challenge. Ann Neurol 3:325-330
8. Gratton JA, Abraham MH, Bradbury MW, Chadha HS (1997) Molecular factors influencing drug transfer across the blood-brain barrier. J Pharm Pharmacol 49:1211-1216
9. Harmar AJ, Horn AS (1976) Octopamine in mammalian brain: rapid post mortem increase and effects of drugs. J Neurochem 26:987-993
10. Keiding S, Sørensen M, Bender D, Munk OL, Ott P, Vilstrup H (2006) Brain metabolism of 13N-ammonia during acute hepatic encephalopathy in cirrhosis measured by positron emission tomography. Hepatology 43:42-50
11. Lockwood AH, McDonald JM, Reiman RE, Gelbard AS, Laughlin JS, Duffy TE, Plum F (1979) The dynamics of ammonia metabolism in man. Effects of liver disease and hyperammonemia. J Clin Invest 63:449-460
12. Lockwood AH, Finn RD, Campbell JA, Richman TB (1980) Factors that affect the uptake of ammonia by the brain: the blood-brain pH gradient. Brain Res 181:259-266
13. Lockwood AH, Yap EW, Wong WH (1991) Cerebral ammonia metabolism in patients with severe liver disease and minimal hepatic encephalopathy. J Cereb Blood Flow Metab 11:337-341
14. Michel H, Solere M, Granier P, Cauvet G, Bali JP, Pons F, Bellet-Herman H (1980) Treatment of cirrhotic hepatic encephalopathy with L-DOPA, a controlled trial. Gastroenterology 79:207
15. Michel H, Bories P, Aubin JP, Pomier Layrargues G, Bauret P, Bellet Herman H (1985) Treatment of acute hepatic encephalopathy in cirrhotics with a branched-chain amino acids enriched versus a conventional amino acids mixture. A controlled study of 70 patients. Liver 5:282-289
16. 13NH3. Stroke 8:694-702
17. 13N-ammonia from blood to brain. Circ Res 48:913-937
18. Sørensen M, Keiding S (2006) Response to Lockwood and Wack: The brain permeability-surface product for ammonia. Hepatology 43:1053-1056
19. Uribe M, Garcia-Ramos G, Ramos M, Valverde C, Marquez MA, Farca A, Guevara L (1983) Standard and higher doses of bromocriptine for severe chronic portal-systemic encephalopathy. Am J Gastroenterol 78:517-522
20. Wahren K, Denis J, Desurmont P, Eriksson LS, Escoffier J-M, Gauthier AP, Hagenfeldt L, Michel H, Opolon P, Paris J-C, Veyrac M (1983) Is intravenous administration of branched chain amino acids effective in the treatment of hepatic encephalopathy? A multicenter study. Hepatology 3:475-480
21. Zieve L, Olsen RL (1977) Can hepatic coma be caused by a reduction of brain noradrenaline or dopamine? Gut 18:688-691